Mitigation of postischemic cardiac contractile dysfunction by CaMKII inhibition: Effects on programmed necrotic and apoptotic cell death

Molecular and Cellular Biochemistry

Volumn 388, Issue 1-2, 2014, Pages 269-276

  Szobi, Adrian ^a   Rajtik, Tomas ^a   Carnicka, Slavka ^b   Ravingerova, Tana ^b   Adameova, Adriana ^a  

^a Physics and Informatics   (Slovakia)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Apoptosis; CaMKII; Ischemia; Myocardium; Necroptosis; Reperfusion

Indexed keywords

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BENZYLAMINES; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROMES C; HEART VENTRICLES; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; NECROSIS; NUCLEAR PORE COMPLEX PROTEINS; PHOSPHORYLATION; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR; RNA-BINDING PROTEINS; SULFONAMIDES;

EID: 84893818468     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1918-x     Document Type: Article

References (34)

1. Hetz CA, Torres V, Quest AF (2005) Beyond apoptosis: nonapoptotic cell death in physiology and disease. Biochem Cell Biol 83(5):579-588 (Pubitemid 41812835)
2. Christofferson DE, Yuan J (2010) Necroptosis as an alternative form of programmed cell death. Curr Opin Cell Biol 22(2):263-268
3. Moquin D, Chan FK (2010) The molecular regulation of programmed necrotic cell injury. Trends Biochem Sci 35(8):434-441
4. Kung G, Konstantinidis K, Kitsis RN (2011) Programmed necrosis, not apoptosis, in the heart. Circ Res 108(8):1017-1036
5. Oerlemans MI, Liu J, Arslan F, den Ouden K, van Middelaar BJ, Doevendans PA, Sluijter JP (2012) Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo. Basic Res Cardiol 107(4):270
6. Smith CC, Davidson SM, Lim SY, Simpkin JC, Hothersall JS, Yellon DM (2007) Necrostatin: a potentially novel cardioprotective agent? Cardiovasc Drugs Ther 21(4):227-233 (Pubitemid 47387468)
7. Linkermann A, Bräsen JH, Himmerkus N, Liu S, Huber TB, Kunzendorf U, Krautwald S (2012) Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury. Kidney Int 81(8):751-761
8. Degterev A, Hitomi J, Germscheid M, Ch'en IL, Korkina O, Teng X, Abbott D, Cuny GD, Yuan C, Wagner G, Hedrick SM, Gerber SA, Lugovskoy A, Yuan J (2008) Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 4(5):313-321 (Pubitemid 351550892)
9. Northington FJ, Chavez-Valdez R, Graham EM, Razdan S, Gauda EB, Martin LJ (2011) Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI. J Cereb Blood Flow Metab 31(1):178-189
10. Sun L, Wang H, Wang Z, He S, Chen S, Liao D, Wang L, Yan J, Liu W, Lei X, Wang X (2012) Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148(1-2):213-227
11. Opie LH, Thandroyen FT (1984) Molecular and biochemical mechanisms underlying the role of calcium ions in malignant ventricular arrhythmias. Ann N Y Acad Sci 427:127-139
12. Jennings RB, Steenbergen C, Reimer KA (1995) Myocardial ischemia and reperfusion. Monogr Pathol 37:47-80
13. Garcia-Dorado D, Ruiz-Meana M, Inserte J, Rodriguez-Sinovas A, Piper HM (2012) Calcium-mediated cell death during myocardial reperfusion. Cardiovasc Res 94(2):168-180
14. 2+ /calmodulin-dependent protein kinase II. Am J Physiol Heart Circ Physiol 295(4):H1669-H1683
15. Salas MA, Valverde CA, Sánchez G, Said M, Rodriguez JS, Portiansky EL, Kaetzel MA, Dedman JR, Donoso P, Kranias EG, Mattiazzi A (2010) The signalling pathway of CaMKII-mediated apoptosis and necrosis in the ischemia/reperfusion injury. J Mol Cell Cardiol 48(6):1298-1306
16. Wu Y, Shintani A, Grueter C, Zhang R, Hou Y, Yang J, Kranias EG, Colbran RJ, Anderson ME (2006) Suppression of dynamic Ca(2 +) transient responses to pacing in ventricular myocytes from mice with genetic calmodulin kinase II inhibition. J Mol Cell Cardiol 40(2):213-223 (Pubitemid 43152378)
17. Zhang R, Khoo MS, Wu Y, Yang Y, Grueter CE, Ni G, Price EE Jr, Thiel W, Guatimosim S, Song LS, Madu EC, Shah AN, Vishnivetskaya TA, Atkinson JB, Gurevich VV, Salama G, Lederer WJ, Colbran RJ, Anderson ME (2005) Calmodulin kinase II inhibition protects against structural heart disease. Nat Med 11(4):409-417 (Pubitemid 40562331)
18. Vila-Petroff M, Salas MA, Said M, Valverde CA, Sapia L, Portiansky E, Hajjar RJ, Kranias EG, Mundiña-Weilenmann C, Mattiazzi A (2007) CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury. Cardiovasc Res 73(4):689-698 (Pubitemid 46227351)
19. Adameova A, Carnicka S, Rajtik T, Szobi A, Nemcekova M, Svec P, Ravingerova T (2012) Upregulation of CaMKIIδ during ischemia-reperfusion is associated with reperfusion-induced arrhythmias and mechanical dysfunction of the rat heart: involvement of sarcolemmal Ca2 + -cycling proteins. Can J Physiol Pharmacol 90(8):1127-1134
20. Couchonnal LF, Anderson ME (2008) The role of calmodulin kinase II in myocardial physiology and disease. Physiology (Bethesda) 23:151-159
21. Sumi M, Kiuchi K, Ishikawa T, Ishii A, Hagiwara M, Nagatsu T, Hidaka H (1991) The newly synthesized selective Ca2 +/calmodulin dependent protein kinase II inhibitor KN-93 reduces dopamine contents in PC12 h cells. Biochem Biophys Res Commun 181(3):968-975
22. Bell JR, Curl CL, Ip WT (2012) Delbridge LM (2012) Ca2 +/calmodulin-dependent protein kinase inhibition suppresses post-ischemic arrhythmogenesis and mediates sinus bradycardic recovery in reperfusion. Int J Cardiol 159(12):112-118
23. Braunwald E, Kloner RA (1985) Myocardial reperfusion: a double-edged sword? J Clin Invest 76(5):1713-1719 (Pubitemid 16196036)
24. Corr PB, Witkowski FX (1984) Arrhythmias associated with reperfusion: basic insights and clinical relevance. J Cardiovasc Pharmacol 6(Suppl 6):S903-S909
25. Wu W, Liu P, Li J (2012) Necroptosis: an emerging form of programmed cell death. Crit Rev Oncol Hematol 82(3):249-258
26. Neuss M, Crow MT, Chesley A, Lakatta EG (2001) Apoptosis in cardiac disease-what is it-how does it occur. Cardiovasc Drugs Ther 15(6):507-523 (Pubitemid 34163937)
27. Adams JM (2003) Ways of dying: multiple pathways to apoptosis. Genes Dev 17(20):2481-2495 (Pubitemid 37271417)
28. Chaitanya GV, Steven AJ, Babu PP (2010) PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. Cell Commun Signal 8:31
29. Lundberg KC, Szweda LI (2004) Initiation of mitochondrial-mediated apoptosis during cardiac reperfusion. Arch Biochem Biophys 432(1):50-57 (Pubitemid 39425028)
30. Chen X, Zhang X, Kubo H et al (2005) Ca2 + influx-induced sarcoplasmic reticulum Ca2 + overload causes mitochondrial-dependent apoptosis in ventricular myocytes. Circ Res 97(10):1009-1017 (Pubitemid 41668914)
31. Szabadkai G, Rizzuto R (2004) Participation of endoplasmic reticulum and mitochondrial calcium handling in apoptosis: more than just neighborhood? FEBS Lett 567(1):111-115 (Pubitemid 38686432)
32. Bagnoli M, Canevari S, Mezzanzanica D (2010) Cellular FLICE-inhibitory protein (c-FLIP) signalling: a key regulator of receptor-mediated apoptosis in physiologic context and in cancer. Int J Biochem Cell Biol 42(2):210-213
33. Yang BF, Xiao C, Li H, Yang SJ (2007) Resistance to Fas-mediated apoptosis in malignant tumours is rescued by KN-93 and cisplatin via downregulation of c-FLIP expression and phosphorylation. Clin Exp Pharmacol Physiol 34(12):1245-1251 (Pubitemid 350013235)
34. Xiao C, Yang BF, Song JH, Schulman H, Li L, Hao C (2005) Inhibition of CaMKII-mediated c-FLIP expression sensitizes malignant melanoma cells to TRAIL-induced apoptosis. Exp Cell Res 304(1):244-255 (Pubitemid 40222091)